CEMQ:F:F-iShares Edge MSCIope Quality Factor UCITS (EUR)

ETF | Others |

Last Closing

USD 10.16

Change

0.00 (0.00)%

Market Cap

USD 0.50B

Volume

N/A

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-04-27 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
PRAJ:F Amundi Index Solutions - Amund..

-0.10 (-0.36%)

USD 139.20B
UIM5:F UBS (Lux) Fund Solutions - MSC..

-0.15 (-0.30%)

USD 113.22B
SXR8:F iShares Core S&P 500 UCITS ETF..

-0.26 (-0.05%)

USD 83.51B
ZPDJ:F SPDR® MSCI Japan UCITS ETF

-0.20 (-0.37%)

USD 77.76B
FRCJ:F UBS MSCI Japan Socially Respon..

-0.09 (-0.40%)

USD 73.13B
EUNL:F iShares Core MSCI World UCITS ..

-0.04 (-0.05%)

USD 72.04B
SXRZ:F iShares VII PLC - iShares Nikk..

-0.65 (-0.29%)

USD 56.29B
XDNY:F Xtrackers MSCI Japan ESG Scree..

-0.02 (-0.16%)

USD 54.81B
VUAA:F Vanguard S&P 500 UCITS Acc

-0.03 (-0.04%)

USD 51.63B
VUSA:F Vanguard Funds Public Limited ..

+0.06 (+0.07%)

USD 51.63B

ETFs Containing CEMQ:F

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 4.57% 53% F 59% D-
Dividend Return N/A N/A N/A N/A N/A
Total Return 4.57% 51% F 55% F
Trailing 12 Months  
Capital Gain 9.64% 57% F 63% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 9.64% 55% F 57% F
Trailing 5 Years  
Capital Gain 51.51% 75% C 73% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 51.51% 75% C 60% D-
Average Annual (5 Year Horizon)  
Capital Gain 9.23% 80% B- 75% C
Dividend Return 9.23% 79% B- 69% C-
Total Return N/A 13% F 23% F
Risk Return Profile  
Volatility (Standard Deviation) 13.72% 46% F 73% C
Risk Adjusted Return 67.25% 90% A- 90% A-
Market Capitalization 0.50B 62% D 50% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.